Hrynkow Sharon Hemond

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$64,621.80
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Hrynkow Sharon Hemond

The largest purchase of all time was on 2018-12-21 and amounted to 40000 shares of Cyclo Therapeutics, Inc. for $26,000.

Biography of Hrynkow Sharon Hemond

No biography is available at this moment.

2022-12-20PurchaseForward Industries, Inc.
FORD
director
9,855
0.0984%
$1.14$11,282-15.26%
2021-12-02PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Scientific Officer
1,000
0.0157%
$4.98$4,980-54.81%
2021-03-29PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Scientific Officer
1,000
0.0197%
$7.46$7,460-3.81%
2019-08-01PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Scientific Officer
10,000
0.0089%
$0.25$2,475-17.39%
2019-07-31PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Scientific Officer
10,000
0.0087%
$0.24$2,425-17.39%
2019-05-31PurchaseCyclo Therapeutics, Inc.
CYTH
Chief Scientific Officer
40,000
0.022%
$0.25$10,000-57.78%
2018-12-21PurchaseCyclo Therapeutics, Inc.
CYTH
SVP for Medical Affairs
40,000
0.0497%
$0.65$26,000-53.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.